Management of rheumatoid arthritis medications and pregnancy

Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology
Yu Funakubo Asanuma

Abstract

Rheumatoid arthritis (RA) affects mainly women during their childbearing years. As aging of childbirth advances in Japan, women who plan pregnancy would increase after they developed RA. Recent findings showed that high disease activity of RA might impair fertility. Planning pregnancy is preferable after female patients achive and maintain low disease activity or remission of RA. Women on methotrexate, which is the anchor drug for RA, need to discontinue the medication with a high risk of causing birth defects during conception and pregnancy. Data of RA patients exposed TNF inhibitors during pregnancy has been accumulating in recent years. These data suggest that increased risk of spontaneous abortion and congenital abnomalies has not been observed. Although there is insufficient data about safety of breastfeeding while using TNF inhibitors, the secretion of the drugs in breast milk is very little and fetal toxicity has not been observed. Since long term safety of children exposed TNF inhibitors in uterus has not been established, we should discontinue the drugs as soon as pregnancy is recognized. TNF inhibitors may be an useful tools for management of active RA resistant to conventional DMARDs in women who desire to bear child...Continue Reading

References

Jun 1, 1990·The American Journal of Medicine·R D KozlowskiA M Segal
Jan 1, 1993·Arthritis and Rheumatism·J L NelsonJ A Hansen
Feb 1, 1997·Rheumatic Diseases Clinics of North America·J L Nelson, M Ostensen
Oct 22, 2005·Annals of the Rheumatic Diseases·J J Cush
Apr 4, 2006·Arthritis and Rheumatism·Patricia P Katz
May 29, 2007·Arthritis and Rheumatism·Yaël A de ManRadboud J E M Dolhain
Sep 2, 2008·Arthritis and Rheumatism·Yaël A de ManJohanna M W Hazes
Dec 17, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Shomron Ben-HorinAlon Lang
May 12, 2010·Journal of Internal Medicine·M NørgaardO Stephansson
Mar 8, 2011·Arthritis and Rheumatism·Damini JawaheerJørn Olsen
Jan 25, 2012·Psycho-oncology·Andrea L Canada, Leslie R Schover
Jul 20, 2012·Swiss Medical Weekly·Frauke FörgerMonika Østensen
Dec 4, 2012·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Uma MahadevanMaria T Abreu
Jan 26, 2013·Clinical Journal of the American Society of Nephrology : CJASN·Kate BramhamCatherine Nelson-Piercy
Dec 20, 2013·Rheumatology·Kimme L Hyrich, Suzanne M M Verstappen
Mar 13, 2014·Current Opinion in Rheumatology·Lisa R Sammaritano, Bonnie L Bermas
May 17, 2014·Annals of the Rheumatic Diseases·Jenny BrouwerRadboud J E M Dolhain
May 21, 2014·Annals of the New York Academy of Sciences·Monika Ostensen

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.